Lannett Company, Inc. (NYSE: LCI) today announced that the U.S. Food and
Drug Administration (FDA) has completed its cGMP compliance inspection
of Lannett’s wholly owned subsidiary Cody Laboratories, Inc. (Cody), a
manufacturer of active pharmaceutical ingredients (APIs) and finished
dosage form products.
Agreement enhances existing relationship between Celladon and Lonza for the manufacture of MYDICAR®
Lonza to initiate design of a new commercial viral therapeutics facility in Portsmouth, NH (USA)
Celladon obtains option to trigger construction of facility and commit to long-term commercial supply
Lonza to purchase $10 million of Celladon common stock upon Celladon's decision to trigger construction and commitment for commercial supply
BASEL, Switzerland and SAN DIEGO, Nov.
Sign-up for 2014/11/3 - AmREIT INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AmREIT, Inc. investment picks
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.